Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2024-09-17

FDA Approved: LACTULOSE — Supplemental Application (Xttrium Laboratories, Inc.)

View source ↗

Summary

FDA approved a supplemental application for lactulose submitted by Xttrium Laboratories, Inc., authorizing a new generic lactulose product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • LACTULOSE (Lactulose)

Snippet

SUPPL AP for LACTULOSE (LACTULOSE)